🇪🇺 Mycograb in European Union

EMA authorised Mycograb on 21 March 2007

Marketing authorisation

EMA — authorised 21 March 2007

  • Application: EMEA/H/C/000658
  • Marketing authorisation holder: NeuTec Pharma plc
  • Local brand name: Mycograb
  • Indication: Treatment of invasive candidiasis in adult patients, in combination with amphotericin B or a lipid formulation of amphotericin B.
  • Status: rejected

Read official source →

Other Other approved in European Union

Frequently asked questions

Is Mycograb approved in European Union?

Yes. EMA authorised it on 21 March 2007.

Who is the marketing authorisation holder for Mycograb in European Union?

NeuTec Pharma plc holds the EU marketing authorisation.